Page 7 - Bevacizumab Injection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

United statesHong kongYong huoEli lillyEquecabtagene autoleucelYujie zhouInnovent biologicsAdimab incyteIncyte corporationUniversity first hospitalAnzhen hospital affiliated to capital medical universityMd anderson cancer centerZhongshan hospital affiliated to fudan universityChina national medical products administrationChina cardiovascular healthClinical development of innovent

Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit

Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Luye pharma groupTechnology platformPhage display technology platformBispecific engager technology platformWorld bispecific summitBoan biotechT cell engagerImprove safetyT cell based approachesHuman antibody transgenic mouseBispecifict cell engager technology platformBevacizumab injection